The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,255.00
Bid: 2,220.00
Ask: 2,290.00
Change: -60.00 (-2.61%)
Spread: 70.00 (3.153%)
Open: 2,295.00
High: 2,240.00
Low: 2,240.00
Prev. Close: 2,300.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

16 Nov 2023 07:00

RNS Number : 6203T
Craneware plc
16 November 2023
 

 

16 November 2023

 

Craneware plc

?

("Craneware" or the "Company" or the "Group")

 

AGM Statement

Craneware (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to provide an update on trading ahead of its Annual General Meeting, which takes place at 10am today.  

 

The Group has enjoyed continued positive financial and operational performance since the start of the new financial year. The partner opportunities which launched at the end of the last financial year continue to gather momentum and the underlying sales pipeline continues to build, converting at an encouraging rate into revenue. With financial results tracking in line with management expectations, we look forward to providing a greater level of detail with our next Trading Update, ahead of our Interim Results.

 

US hospitals are now returning their attention to providing Value-Based Care and building resilience into their operating models through greater insights into their financials and operations. Through Trisus, our cloud-based data analytics and intelligence platform, we plan to be a central player in the digitalisation, the use of data to provide insights that improve the processes, of US healthcare. The team is focused on capturing this opportunity through market expansion and the delivery of increased value to our extensive hospital customer base.

 

We are confident that our resilient business model, extensive customer base, high levels of Annual Recurring Revenue, together with our strategy for delivering growth centred on the expansion of the Trisus platform, will enable us to create further long-term value for all our stakeholders.   

 

For further information, please contact:

 

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon

craneware@almastrategic.com

 

Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers

 

Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

  

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons

 

 

About Craneware

 

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDBBDBCXBDGXU
Date   Source Headline
9th Nov 20188:55 amRNSDividend Currency Election
7th Nov 201810:42 amRNSResult of AGM
6th Nov 20187:00 amRNSAGM Statement and Capital Markets Day
16th Oct 20187:00 amRNSBlock listing Interim Review
11th Oct 201810:50 amRNSPosting of Annual Report and Notice of AGM
5th Oct 20184:39 pmRNSTotal Voting Rights
5th Oct 20182:55 pmRNSHolding(s) in Company
18th Sep 20182:06 pmRNSSecond Price Monitoring Extn
18th Sep 20182:00 pmRNSPrice Monitoring Extension
11th Sep 201811:10 amRNSHolding(s) in Company
10th Sep 20187:00 amRNSDirector/PDMR Shareholding
7th Sep 201811:40 amRNSHolding(s) in Company
5th Sep 201812:20 pmRNSGrant of Options & Long Term Incentive Plan Awards
4th Sep 20187:00 amRNSFinal Results
1st Aug 20187:00 amRNSAppointment of Joint Broker
10th Jul 20187:00 amRNSTrading Update and Significant Contract Win
17th Apr 20181:55 pmRNSBlock listing Interim Review
12th Apr 20189:54 amRNSHolding(s) in Company
6th Apr 20183:10 pmRNSDividend Currency Election
27th Mar 20181:52 pmRNSHolding(s) in Company
19th Mar 20187:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
14th Mar 20182:11 pmRNSAdditional Listing - Blocklisting of Securities
8th Mar 20187:00 amRNSDirector/PDMR Shareholding
6th Mar 20187:00 amRNSHalf-year Report
16th Feb 201811:53 amRNSHolding(s) in Company
13th Feb 20187:00 amRNSSignificant Contract Wins
31st Jan 20182:59 pmRNSTotal Voting Rights
26th Jan 20182:49 pmRNSHolding(s) in Company
26th Jan 201812:10 pmRNSTotal Voting Rights and Director/PDMR Shareholding
23rd Jan 201812:05 pmRNSResult of Share Buyback
17th Jan 20185:59 pmRNSGrant of Options & Long Term Incentive Plan Awards
16th Jan 20187:00 amRNSShare Buyback
8th Jan 20187:00 amRNSTrading Update and Significant Contract Win
29th Nov 20177:00 amRNSHolding(s) in Company
10th Nov 20171:43 pmRNSDividend Currency Election
8th Nov 20175:00 pmRNSResult of AGM
8th Nov 20177:00 amRNSAGM Statement
31st Oct 20177:00 amRNSSignificant Contract Win
27th Oct 20172:07 pmRNSHolding(s) in Company
18th Oct 20172:06 pmRNSBlock listing Interim Review
12th Oct 201712:15 pmRNSPosting of Annual Report and Notice of AGM
22nd Sep 201712:06 pmRNSHolding(s) in Company
5th Sep 20177:00 amRNSFinal Results
11th Jul 20177:00 amRNSTrading Update
5th Apr 20177:00 amRNSHolding(s) in Company
31st Mar 20175:04 pmRNSDividend Currency Election
27th Mar 20176:26 pmRNSGrant of Options & Long Term Incentive Plan Award
23rd Mar 20177:00 amRNSSignificant Contract Win
7th Mar 20177:00 amRNSHalf-year Report
31st Jan 20177:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.